Verastem Inc
NASDAQ:VSTM

Watchlist Manager
Verastem Inc Logo
Verastem Inc
NASDAQ:VSTM
Watchlist
Price: 3.96 USD -0.75% Market Closed
Updated: Jun 2, 2024

Verastem Inc
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Verastem Inc
Current Portion of Long-Term Debt Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Verastem Inc
NASDAQ:VSTM
Current Portion of Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Current Portion of Long-Term Debt
$10.2B
CAGR 3-Years
-3%
CAGR 5-Years
45%
CAGR 10-Years
88%
Gilead Sciences Inc
NASDAQ:GILD
Current Portion of Long-Term Debt
$3.7B
CAGR 3-Years
18%
CAGR 5-Years
8%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Current Portion of Long-Term Debt
$4B
CAGR 3-Years
37%
CAGR 5-Years
1%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Verastem Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
0 USD

Based on the financial report for Dec 31, 2023, Verastem Inc's Current Portion of Long-Term Debt amounts to 0 USD.